on Zymo Research Corp.
Zymo Research Forms Strategic Alliance with biomodal for Advanced Multiomic Insights
Zymo Research, a global frontrunner in next-generation sequencing (NGS), has announced a strategic partnership with biomodal, a life sciences technology and analytics company. This collaboration will see Zymo Research’s NGS services division leveraging biomodal’s duet multiomics solutions to offer enhanced genetic and epigenetic insights from a single DNA sample.
This partnership strengthens Zymo Research’s NGS services portfolio, allowing simultaneous analysis of 5hmC, 5mC, and genetic sequences. Dr. Keith Booher, Director of NGS Services, stated that this innovation represents a significant technological advancement in epigenetics and biomedical research.
The collaboration aims to transform molecular biology research by enabling comprehensive analyses across various scientific fields such as oncology and neurobiology. This initiative promises to deepen the understanding of gene regulation and disease mechanisms.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Zymo Research Corp. news